IMV

imv-logo

IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape.

#SimilarOrganizations #People #Financial #Website #More

IMV

Social Links:

Industry:
Biotechnology Health Care

Founded:
2000-01-01

Address:
Dartmouth, Nova Scotia, Canada

Country:
Canada

Website Url:
http://www.imv-inc.com

Total Employee:
11+

Status:
Active

Contact:
+1 (902) 492-1819

Total Funding:
79.6 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache


Similar Organizations

arch-oncology-logo

Arch Oncology

Arch Oncology is an immuno-oncology company

atom-bioscience-pharmaceutical-logo

Atom Bioscience & Pharmaceutical

Atom Bioscience is a clinical-stage biotechnology company.

beyeonics-logo

Beyeonics

A Surgical visualization company.

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

disc-medicine-logo

Disc Medicine

Disc Medicine is a hematology company

endpoint-health-logo

Endpoint Health

Precision Immunology Therapies

epicentrx-inc-logo

EpicentRx Inc

EpicentRx Inc is a clinical-stage immuno-oncology company.

excellthera-logo

ExCellThera

ExCellThera is an advanced clinical stage biotechnology company.

iconovir-bio-logo

IconOVir Bio

IconOVir Bio is a preclinical-stage biotechnology company.

immuneid-logo

ImmuneID

ImmuneID is a precision immunology company.

leap-therapeutics-logo

Leap Therapeutics

Leap Therapeutics is a clinical-stage biopharmaceutical company.

lion-tcr-logo

Lion TCR

Lion TCR is a clinical-stage biotechnology company.

medicenna-therapeutics-logo

Medicenna Therapeutics

Medicenna is a clinical stage, privately held, immuno-oncology company.

nanology-logo

NanOlogy

NanOlogy™ is a clinical-stage oncology company

ocugen-logo

Ocugen

Ocugen is a clinical stage biopharmaceutical company.

olix-pharmaceuticals-logo

OliX Pharmaceuticals

OliX is a clinical stage biotechnology company.

paragon-genomics-inc-logo

Paragon Genomics, Inc.

provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research

semler-scientific-logo

Semler Scientific

Semler Scientific is an emerging medical risk-assessment company.

the-honeycomb-clinic-logo

The Honeycomb Clinic

Medical Co-Working Space

umobile-logo

uMobile

UMobile is an application developing company.

Current Employees Featured

jeremy-r-graff_image

Jeremy R. Graff
Jeremy R. Graff Chief Scientific Officer @ IMV
Chief Scientific Officer
2021-06-01

andrew-hall_image

Andrew Hall
Andrew Hall CEO @ IMV
CEO

not_available_image

Robert Brown
Robert Brown Co - Founder @ IMV
Co - Founder

andrew-hall_image

Andrew Hall
Andrew Hall Chief Business Officer & Interim CEO @ IMV
Chief Business Officer & Interim CEO
2021-08-01

Founder


not_available_image

Robert Brown

Stock Details


Company's stock symbol is NASDAQ:IMV

Investors List

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Post-IPO Equity - IMV

lumira-ventures_image

Lumira Ventures

Lumira Ventures investment in Post-IPO Equity - IMV

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Post-IPO Equity - IMV

Official Site Inspections

http://www.imv-inc.com Semrush global rank: 1.19 M Semrush visits lastest month: 25.9 K

  • Host name: 172.67.195.176
  • IP address: 172.67.195.176
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "IMV"

IMV Inc - Crunchbase Company Profile & Funding

IMV Inc Inc. applies its novel adjuvanting platform to the development of vaccines for cancer therapy, infectious diseases and animal health. The Company’s …See details»

IMV Inc. - LinkedIn

IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform: the DPX® technology.See details»

Investor Relations :: IMV Inc. (IMV)

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and …See details»

IMV Inc. (IMVIF) Company Profile & Description - Stock Analysis

Mar 4, 2025 IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX, an immune-educating technology platform for …See details»

Court grants creditor protection to N.S. company developing …

IMV said it had enough drug supply to ensure patients already in screening or enrolled in ongoing trials before May 1 will be able to receive treatment. The company has received more than $5 ...See details»

Annual Report - IMV CORPORATION

Feb 14, 2025 IMV EUROPE LIMITED. 1 Dunsbridge Business Park, Shepreth, Royston, Herts, SG8 6RA, UKSee details»

Corporate Information - IMV CORPORATION

IMV contributes to the safety and security of the world through its business and contributes to the realization of a sustainable society. View More. Corporate Outline. This section includes a …See details»

IMV Inc. - Canada.ca

Out of that innovation grew IMV Inc., and a potential cure for many cancers. “We are now one of the most advanced companies in the world working on immunotherapy,” says the Halifax …See details»

IMV Inc. Announces Strategic Reorganization - BioSpace

Sep 15, 2022 IMV Inc. is a clinical-stage immuno-oncology company advancing a portfolio of therapies based on the Company’s immune-educating platform, DPX ®. Through a …See details»

Immunovaccine Announces 2009 Year End Results :: IMV Inc. (IMV)

HALIFAX, NOVA SCOTIA -- (MARKET WIRE) -- 04/19/10 -- Immunovaccine Inc. (TSX VENTURE: IMV) ("Immunovaccine" or the "Company"), a vaccine development company, …See details»

IMV Appoints Andrew Hall as Chief Executive Officer - IMV Inc.

Dec 22, 2021 DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- IMV Inc. (NASDAQ: IMV; TSX: IMV), (“IMV” or “the Company”), a clinical-stage company …See details»

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL …

VANCOUVER, BC, Feb. 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has …See details»

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL …

VANCOUVER, BC, Feb. 21, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announce has completed the …See details»

IMV Inc. | LinkedIn

IMV Inc. | 3,950 followers on LinkedIn. Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers | IMV Inc. is a clinical …See details»

IMV Inc. Provides Clinical and Operational Update and Announces …

IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results. Phase 2 SPiReL study of DPX-Survivac combination regimen with Keytruda® in r/r …See details»

Immunovaccine and Leidos Expand Collaboration to Develop …

HALIFAX, Nova Scotia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immunotherapy and vaccine company, today announced …See details»

Working at IMV Inc: Employee Reviews | Indeed.com

Nov 13, 2024 Reviews from IMV Inc employees about IMV Inc culture, salaries, benefits, work-life balance, management, job security, and more.See details»

Filed by e3 Filing, Computershare 1-800-973-3274 - IMV Inc.

IMV Inc. (Name of registrant) 130 Eileen Stubbs Avenue, Suite 19 Dartmouth, Nova Scotia B3B 2C4, Canada ... is also an active member of the research organization Society of Gynecologic …See details»

Imv Inc: Et si on réalisait enfin la promesse de fabriquer des …

IMV Inc. est une société d’immuno-oncologie au stade clinique qui a des installations à Dartmouth (Nouvelle-Écosse) et à Boston (Massachusetts). IMV développe un portefeuille de thérapies …See details»

IMV to Host a Key Opinion Leader Webcast on the Ovarian Cancer ...

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)-- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and …See details»

linkstock.net © 2022. All rights reserved